doi:

DOI: 10.3724/SP.J.1008.2010.00545

Academic Journal of Second Military Medical University (第二军医大学学报) 2010/30:5 PP.545-548

Endothelial progenitor cells: functions and clinical application in cardiac and vascular diseases


Abstract:
Circulating endothelial progenitor cells (EPCs) derived from bone marrow are capable of endocrine, reendothelialization of injured blood vessels and neovascularization of ischemic lesions; besides, they also play a major role in the pathogenesis of atherosclerosis. However, the number and functions of circulating EPCs are greatly declined in patients suffering from cardiovascular diseases. Functions of EPCs are associated with not only pathophysiological factors such as aging, hypertension, diabetes and hyperlipidemia, but also personal lifestyle such as exercise, body weight and smoking, which directly influence the development of cardiovascular diseases. In this review, we mainly focus on the relationship between EPCs and cardiovascular risk factors and the potential roles of EPC therapy for cardiovascular diseases.

Key words:endothelial progenitor cells,cardiovascular diseases,risk factors,therapeutic uses

ReleaseDate:2014-07-21 15:18:42



[1] Pacilli A,Pasquinelli G.Vascular wall resident progenitor cells:a review[J].Exp Cell Res,2009,315:901-914.

[2] Sirker A A,Astroulakis Z M,Hill J M.Vascular progenitor cells and translational research: the role of endothelial and smooth muscle progenitor cells in endogenous arterial remodelling in the adult[J].Clin Sci (Lond),2009,116:283-299.

[3] Mobius-Winkler S,Hollriegel R,Schuler G,Adams V.Endothelial progenitor cells: implications for cardiovascular disease[J].Cytometry A,2009,75:25-37.

[4] Hristov M,Erl W,Weber P C.Endothelial progenitor cells: isolation and characterization[J].Trends Cardiovasc Med,2003,13:201-206.

[5] He T,Lu T,d'Uscio L V,Lam C F,Lee H C,Katusic Z S.Angiogenic function of prostacyclin biosynthesis in human endothelial progenitor cells[J].Circ Res,2008,103:80-88.

[6] He T,Smith L A,Harrington S,Nath K A,Caplice N M,Katusic Z S.Transplantation of circulating endothelial progenitor cells restores endothelial function of denuded rabbit carotid arteries[J].Stroke,2004,35:2378-2384.

[7] Hur J,Yoon C H,Kim H S,Choi J H,Kang H J,Hwang K K,et al.Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis[J].Arterioscler Thromb Vasc Biol,2004,24:288-293.

[8] Umemura T,Higashi Y.Endothelial progenitor cells: therapeutic target for cardiovascular diseases[J].J Pharmacol Sci,2008,108:1-6.

[9] Griese D P,Ehsan A,Melo L G,Kong D,Zhang L,Mann M J,et al.Isolation and transplantation of autologous circulating endothelial cells into denuded vessels and prosthetic grafts: implications for cell-based vascular therapy[J].Circulation,2003,108:2710-2715.

[10] Takahashi T,Kalka C,Masuda H,Chen D,Silver M,Kearney M,et al.Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization[J].Nat Med,1999,5:434-438.

[11] Kocher A A,Schuster M D,Szabolcs M J,Takuma S,Burkhoff D,Wang J,et al.Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis,reduces remodeling and improves cardiac function[J].Nat Med,2001,7:430-436.

[12] Vasa M,Fichtlscherer S,Aicher A,Adler K,Urbich C,Martin H,et al.Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease[J].Circ Res,2001,89:E1-E7.

[13] Vasa M,Fichtlscherer S,Adler K,Aicher A,Martin H,Zeiher A M,et al.Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease[J].Circulation,2001,103:2885-2890.

[14] Huang P H,Chen Y H,Chen Y L,Wu T C,Chen J W,Lin S J.Vascular endothelial function and circulating endothelial progenitor cells in patients with cardiac syndrome X[J].Heart,2007,93:1064-1070.

[15] Shimada T,Takeshita Y,Murohara T.Angiogenesis and vasculogenesis are impaired in the precocious-aging klotho mouse[J].Circulation,2004,110:1148-1155.

[16] Scheubel R J,Zorn H,Silber R E,Kuss O,Morawietz H,Holtz J,et al.Age-dependent depression in circulating endothelial progenitor cells in patients undergoing coronary artery bypass grafting[J].J Am Coll Cardiol,2003,42:2073-2080.

[17] Thum T,Hoeber S,Froese S,Klink I,Stichtenoth D O,Galuppo P,et al.Age-dependent impairment of endothelial progenitor cells is corrected by growth-hormone-mediated increase of insulin-like growth-factor-1[J].Circ Res,2007,100:434-443.

[18] Beauséjour C.Bone marrow-derived cells: the influence of aging and cellular senescence[J].Handb Exp Pharmacol,2007(180):67-88.

[19] Michaud S E,Dussault S,Haddad P,Groleau J,Rivard A.Circulating endothelial progenitor cells from healthy smokers exhibit impaired functional activities[J].Atherosclerosis,2006,187:423-432.

[20] Werner N,Kosiol S,Schiegl T,Ahlers P,Walenta K,Link A,et al.Circulating endothelial progenitor cells and cardiovascular outcomes[J].N Engl J Med,2005,353:999-1007.

[21] Zhou B,Ma F X,Liu P X,Fang Z H,Wang S L,Han Z B,et al.Impaired therapeutic vasculogenesis by transplantation of OxLDL-treated endothelial progenitor cells[J].J Lipid Res,2007,48:518-527.

[22] Thum T,Fraccarollo D,Schultheiss M.Endothelial nitric oxide synthase uncoupling impairs endothelial progenitor cell mobilization and function in diabetes[J].Diabetes,2007,56:666-674.

[23] Redondo S,Hristov M,Gumbel D,Tejerina T,Weber C.Biphasic effect of pioglitazone on isolated human endothelial progenitor cells: involvement of peroxisome proliferator-activated receptor-gamma and transforming growth factor-beta1[J].Thromb Haemost,2007,97:979-987.

[24] Liu J F,Wang B W,Hung H F,Chang H,Shyu K G.Human mesenchymal stem cells improve myocardial performance in a splenectomized rat model of chronic myocardial infarction[J].J Formos Med Assoc,2008,107:165-174.

[25] Erbs S,Linke A,Adams V,Lenk K,Thiele H,Diederich K W,et al.Transplantation of blood-derived progenitor cells after recanalization of chronic coronary artery occlusion: first randomized and placebo-controlled study[J].Circ Res,2005,97:756-762.

[26] Schachinger V,Erbs S,Elsasser A,Haberbosch W,Hambrecht R,Holschermann H,et al.Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction[J].N Engl J Med,2006,355:1210-1221.

[27] Seiler C,Pohl T,Wustmann K,Hutter D,Nicolet P A,Windecker S,et al.Promottion of collateral growth by granulocyte-stimulating factor in patients with coronary artery disease[J].Circulation,2001,104:2012-2017.

[28] Aoki J,Serruys P W,van Beusekom H,Ong A T,McFadden E P,Sianos G,et al.Endothelial progenitor cell capture by stents coated with antibody against CD34: the HEALING-FIM (Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth-First In Man) Registry[J].J Am Coll Cardiol,2005,45:1574-1579.

[29] Seth S,Narang R,Bhargava B,Ray R,Mohanty S,Gulati G,et al.Percutaneous intracoronary cellular cardiomyoplasty for nonischemic cardiomyopathy: clinical and histopathological results: the first-in-man ABCD (Autologous Bone Marrow Cells in Dilated Cardiomyopathy) trial[J].J Am Coll Cardiol,2006,48:2350-2351.

[30] Higashi Y,Kimura M,Hara K,Noma K,Jitsuiki D,Nakagawa K,et al.Autologous bone-marrow mononuclear cell implantation improves endothelium-dependent vasodilation in patients with limb ischemia[J].Circulation,2004,109:1215-1218.